Need
to Reform Intellectual Property Laws
Sam Ghandchi
http://www.ghandchi.com/718-intellectual-property-eng.htm
Persian Version متن فارسی
http://ir.voanews.com/content/blog/1509263.html
Adam Smith in the beginning of his Wealth of Nations compares
hunter-gatherer societies with the agricultural societies, which have
domesticated animals, and writes that the latter can accumulate its product, and
for the product, he gives the example of cattle. In fact, the difference between
a wild deer and a domesticated cow is in the latter being controllable, and
ultimately with the guarantee of law and state, can be owned as property.
Inventions or software, in countries where the rights are secured by the state,
is different from free thought and science that had existed for centuries even
in ancient societies, because this new phenomena can be controlled and owned,
and thus represents a new form of wealth referred to as intellectual property.
In industrial society a limited number of products such as books or paintings
were defined as intellectual property by being protected under copyright laws.
But in post-industrial societies we are seeing a myriad of such products with
millions of patents registered in different countries, as this new kind of
property is the main part of wealth in new economies, surpassing industrial and
agricultural properties in their value.
The most important products of post-industrial society are comprised of codified
knowledge as explained thoroughly by Daniel Bell in the 1999 Preface to his book
The Coming of Post-Industrial. What he calls codified knowledge, today is easily
seen in the complex design of ASICs in the production of semiconductors, and
such designs, separate the real post-industrial economies from old
service-oriented economies.
It took centuries before agricultural and industrial property rights were
established in the world and the fairness of the laws concerning those forms of
property were examined. Intellectual property in contrast is a very new
phenomena and the laws governing it that have been passed on from the industrial
society were centered around things like books or music records and can hardly
be considered flawless when applied to new post-industrial intellectual property
such as patents on pharmaceutical drugs. In addition, long court battles have
been fought over patent-eligibility, such as for human genes, with a recent
court ruling in favor of gene patents, showing the lack of clarity surrounding
intellectual property laws (1).
This is why many different enterprises in the post-industrial economies have
challenges to meet when facing the issues surrounding the music industry on the
Internet, for example the legal battles that shut down Napster. But the
challenges are not limited to music industry. In fact, the drug and
pharmaceutical sector is facing a real dilemma when using old laws to fit the
new products. For example, generic drugs made in India are orders of magnitude
cheaper than their counterparts in the United States, and the copyright battles
between Cipla and Roche are as hot as the patent wars of Apple and Samsung in
computer business (2).
Recently an issue has come up about anti-venom medicine a patient needed which
cost $39,652 in Arizona state of the U.S. whereas the same medicine costs $100 a
few miles away in Mexico (3).
A lot of times, many of the intellectual property patents are not even developed
by their registrants and they wait for others to develop it and then to claim
royalty. This is like those who owned barren land in the past but did not
develop and waited for land to appreciate its value to sell. The Homestead Act
in 1862 in the U.S. put a five year limit for one to develop such lands.
It is time to reexamine the intellectual property laws especially in light of
global economy and make them more based on international criteria especially
when they are being applied beyond nation states.
Sam Ghandchi, Editor/Publisher
IRANSCOPE
http://www.iranscope.com
September 17, 2012
Footnote:
1.
http://www.natlawreview.com/article/federal-circuit-reaffirms-patentability-isolated-dna-association-molecular-pathology
2.
http://in.reuters.com/article/2012/09/07/india-roche-cipla-idINL4E8K73UQ20120907
3.
http://www.azcentral.com/arizonarepublic/opinions/articles/2012/09/06/20120906editorial0907-antivenom-bills-sting.html